IPO Boutique Research, Color & More Information for Subscribers
This past week five IPOs debuted, zero updated terms and one new deal was filed. The trend in the IPO market continued as buy-side investors dictated pricings for new issues that came to the market. Of the five deals that debuted this past week, three priced below range and two priced at the low end[…]
This past week six IPOs debuted, four updated terms and six new deals were filed. There were seven IPOs on the schedule to debut this week and many of them were priced to the markets satisfaction and thus performed nicely. Four of the six deals that debuted priced within its initial range. The success this[…]
This past week zero IPOs debuted, ten updated terms and two new deals were filed. There were two IPOs on the schedule to debut this week, however, neither had the demand needed to successfully come to market. According to the underwriter, the Xtera Communications (Nasdaq: XCOM) deal has been pushed to next week. Please refer[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Wednesday, November 11 Advanced Accelerated Applications (Nasdaq: AAAP) Equity Bancshares (Nasdaq: EQBK) Voyager Therapeutics (Nasdaq: VYGR) Wave Life Sciences (Nasdaq: WVE) Friday, November 11[…]
This past week two IPOs debuted, three updated terms and zero new deals were filed. Both IPOs that debuted this week came to market successfully but only after needing a severe price reduction. MyoKardia (Nasdaq: MYOK) priced its deal at $10.00—a whopping $5.00 below the initial $15-$17 range. The deal opened with a $1.08 premium[…]
This past week four IPOs debuted, one updated terms and ten new deals were filed. The week’s high profile deal, Ferrari N.V. (NYSE: RACE), was the only IPO of the four at opening to debut this week- that did not disappoint. Ferrari priced a full size deal at the high end of the range, $52,[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Tuesday, October 20 American Farmland Company (NYSE: AFCO) Wednesday, October 21 Ferrari (NYSE: RACE) Thursday, October 22 Dimension Therapeutics (Nasdaq: DMTX) Multi Packaging Solutions[…]
If you own a Ferrari, the branding sends a message that goes beyond four wheels, but a status symbol. On October 21, investors will get a chance to jump in this ride via the company’s IPO.
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Thursday, October 15 Albertson’s Companies (NYSE: ABS) First Data Corporation (NYSE: FDC) Fuling Group Limited (Nasdaq: FORK) Friday, October 16 American Farmland Company (NYSE:[…]
This past week five IPOs debuted, three updated terms and seven new deals were filed. Of the five deals that debuted this week, four needed to price significantly below their initial ranges in order to come to market. The single deal that was priced in-range, Pure Storage (NYSE: PSTG), opened $0.26 below its $17.00 IPO price[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Wednesday, October 7 Aclaris Therapeutics (Nasdaq: ACRS) Pure Storage, Inc. (NYSE: PSTG) Thursday, October 8 CytomX Therapeutics (Nasdaq: CTMX) Allegiance Bancshares (Nasdaq: ABTX) CPI[…]
This past week five IPOs debuted, five updated terms and two new deals were filed. Of the five deals that debuted this past week, two opened below their offering prices and one opened flat. Each deal that opened for trade, needed their terms adjusted to fit the buy-side bids. Edge Therapeutics (Nasdaq: EDGE) was the[…]
The IPO market came to pretty much a screeching halt in September as just three deals debuted. In September 2014 a total of 14 IPOs debuted. Thus far in 2015, a total of 120 IPOs have priced as compared to 192 that priced at the same point a year ago. This post will allow us[…]
The third quarter is in the books, and it was a slow period for the IPO market with only 30 deals having debuted. You can look at how we rated each individual deal at our track record page. Below is how the statistics of how the major underwriter banks fared this quarter and year-to-date. The[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Wednesday, September 30 Mirna Therapeutics (Nasdaq: MRNA) Thursday, October 1 Surgery Partners (Nasdaq: SGRY) Edge Therapeutics (Nasdaq: EDGE) Performance Food Group Company (NYSE: PFGC)[…]
An IPO rumored for weeks, Pure Storage (NYSE: PSTG), set terms on Thursday morning for a deal that is set to debut on October 7. Pure Storage transforms business through a dramatic increase in performance and reduction in complexity and costs. Their innovative technology replaces storage systems designed for mechanical disk with all-flash systems optimized[…]
The IPO market is getting ready for a late 2015 run. Five deals from higher-tier underwriters are on the schedule for next week and two other deals have already been slated for the Week of October 5th. Please refer to the home page for a look at all IPOs and Secondary’s currently on the schedule.[…]
This past week three IPOs debuted, four updated terms and two new deals filed. Among the three deals that debuted, two had strong demand from investors and had successful debuts accordingly. REGENXBIO (Nasdaq: RGNX) upsized its deal, increased its range in a filing—ultimately pricing the deal $3.00 above the initial $17-$19 range. The deal opened[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Thursday, September 17 REGENXBIO, Inc (Nasdaq: RGNX) Friday, September 18 Nabriva Therapeutics (Nasdaq: NBRV) Penumbra (NYSE: PEN)
Once again this week, there are currently no deals on the schedule set to debut. We continue to reiterate that this period is the traditional slow period or ‘lull’ in the IPO market. We would not at all be surprised to see company’s begin to set terms the week after Labor Day. One company with[…]